If you missed us this year at #PMWS, don't worry! Catch up with our Director of Business Development, Peter Genest, and Chief Technology Officer of BlueRock Therapeutics, Craig Beasley. Learn from our alumni member, #Bluerock Therapeutics, about the challenges they faced in developing #CellTherapies during early discovery research. Gain valuable insights from industry experts and uncover strategies to navigate your own journey. To watch the interview visit: https://hubs.ly/Q02zTMNX0 #CellTherapy #DrugDiscovery #ClinicalTrials #DrugDevelopment #DrugManufacturing #ClinicalData #Biotech #Pharma #Lifescience #Pharmaceutical #Innovation #Technology
SmartLabs’ Post
More Relevant Posts
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Samsung invests in pre-clinical-stage biotech BrickBio - The Pharma Letter >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #competitivemarketing #pharmaceutical #healthcare
Google News
thepharmaletter.com
-
What are the challenges, technological innovation needs, and major trends currently present in the biopharmaceutical and biotechnology industries? I wrote a blog that discusses the recent technological advancements within the future-driven biopharma sector and highlights Timegate's continuous efforts to cater to the industry by consistently refining our offerings to meet the evolving needs of our customers. The blog also provides an overview of Timegate's performance in 2023 and emphasizes our commitment to growth and innovation in the upcoming year of 2024. Have a read and feel free to contact me if you have any thoughts! #timegating #processmonitoring #biopharma #biotechnology #development
Timegate CEO's greetings for the year 2024
timegate.com
-
Thoughts on this? >> Samsung invests in pre-clinical-stage biotech BrickBio - The Pharma Letter >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #pharma #pharmaceutical #biotech
Google News
thepharmaletter.com
-
Veeda Biopharma stands at the forefront of utilizing cutting-edge infrastructure to propel the advancement of various biopharmaceutical solutions. Our dedication to excellence is evident in a range of specialized programs that cover: - Analytics & Characterization - Bioprocess Development - Discovery Biology - Clinical Bioanalysis Explore our infrastructure driving research and development across a diverse range of solutions, advancing movement of molecules from discovery to market with remarkable Speed and Precision. Visit our page https://bit.ly/3TjEdpt to discover more about our Integrated Bioanalytical and Non-clinical Characterization Solutions. You can also write to us at info@veedacr.com to discuss your Biopharmaceutical needs. Partners in creating a healthier tomorrow. #Veeda #VeedaCR #VeedaClinicalResearch #VeedaBiopharma #Infrastructure #Characterization #Biopharmaceutical #Bioanalytical
-
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among the many factors that need to be considered when designing your next biopharmaceutical facility. Read more about this track, which will be featured at the 2024 Biotechnology Conference: https://hubs.la/Q02sHgDq0 #ISPE #ISPEBiotechnology #Biotech
Challenges and Trends in Biopharmaceutical Facility Design
ispe.org
-
🌟 Discover how leveraging Design of Experiments (DoE) can revolutionize your pharmaceutical company's entire value chain! In the realm of research, DoE plays a pivotal role in disease exploration, compound analysis, and preclinical investigations. Unleash the power of DoE for streamlined compound development, defining the design space, and ensuring potency. Embrace the benefits: 🔹 Significant time savings 🔹 Reduced costs 🔹 Elevated product quality 🔹 Enhanced robustness To learn more about how DoE can help you increase value follow our LI page or visit https://lnkd.in/eqFBFM9i. #designofexperiments #OMARS #optimization #modeling #pharmaceuticals #dataanalysis #qualitycontrol #experimentaldesign
-
-
🔬 Don't Miss Out on Our Exclusive On-Demand Webinar! 🔬 In this insightful webinar, our panel of Experts will unravel key considerations and best practices to guide you in selecting the perfect bioreactor controls platform for your biopharmaceutical endeavors. ✔ Discover the crucial factors to consider when choosing your bioreactor controls platform. ✔ Learn how to support a platform that seamlessly scales up from lab to pilot to manufacturing, accommodating your evolving needs and growth. ✔ Explore strategies for future-proofing your bioreactor control platforms. ✔ Gain insights into the range of Catalyx bioreactor control platforms available to support different processes. Don't miss this opportunity to expand your knowledge and optimize your bioprocessing endeavors! 💡🚀 https://lnkd.in/enA7EZE8 #BioreactorControls #CellCulture #Biopharmaceuticals #CatalyxWebinar #Innovation #BioprocessingExcellence
On-Demand Webinar: Key considerations when selecting bioreactor controls for modern cell culture operations
https://catalyx.ai
-
🎥In this short video, our #continuousmanufacturing expert Nick Hutchinson summaries the advantages of our agile J.POD facilities for #biologics manufacturing, when compared to traditional stainless-steel facilities. 🌐Check out our more detailed blog post here: https://hubs.ly/Q02q63QF0 #Researchneverstops #antibody #biotherapeutics
Are you looking for a more flexible and cost-effective way to produce #biopharmaceuticals? If so, you might be interested in learning more about the J.POD facilities that we have developed in Redmond, USA and Toulouse, France. J.POD facilities are modular and scalable production units that use single-use technologies to reduce the need for expensive and complex plant utilities. They can be easily constructed and commissioned in a fraction of the time and cost of traditional stainless-steel facilities. J.POD facilities also offer a high degree of agility and responsiveness to changing market demands. They can be rapidly deployed and relocated to meet the needs of different customers and regions. They can also adjust their production capacity and output by adding or removing modules as needed. J.POD facilities leverage a continuous manufacturing platform that enables a seamless and efficient production process from cell culture to purification. This results in higher yields, lower costs, and shorter timelines for biopharmaceutical manufacturing. If you want to learn more about how J.POD facilities are transforming the biopharmaceutical industry, check out our latest blog post here - https://hubs.ly/Q02q63QF0 We are excited to share our vision and expertise with you and look forward to hearing your feedback and questions. Feel free to comment below or contact us directly. Thank you for your interest and support! #researchneverstops
-
As biopharmaceutical companies pioneer new molecules and treatments, it is evident that the stability of these molecules is becoming a detrimental factor with every iteration and that lyophilization is the pathway to a solution. At PCI Pharma Services, we believe lyophilization cycle development is not only a science but an art. Each drug product that comes into our laboratories presents unique challenges, and the design of a cycle requires an understanding of individual chemistry, characteristics, and interactions to yield a high-quality product. Read our latest case study to learn how we partnered with a small US-based biotech client to develop a strategic three-part lyophilization cycle development plan for their labile monoclonal antibody to address not only their short-term objective of advancing the product into the clinic but also to plan for the later stage clinical trial program and ultimately commercialization. https://lnkd.in/gsR8MKHR #Lyophilization #Biotech #CDMO #LetsTalkFuture
-
-
🌟 Discover how leveraging Design of Experiments (DoE) can revolutionize your pharmaceutical company's entire value chain! In the realm of research, DoE plays a pivotal role in disease exploration, compound analysis, and preclinical investigations. Unleash the power of DoE for streamlined compound development, defining the design space, and ensuring potency. Embrace the benefits: 🔹 Significant time savings 🔹 Reduced costs 🔹 Elevated product quality 🔹 Enhanced robustness To learn more about how DoE can help you increase value follow our LI page or visit https://lnkd.in/d9bpVGH7. #designofexperiments #OMARS #optimization #modeling #pharmaceuticals #dataanalysis #qualitycontrol #experimentaldesign
-
